Largest biotech by total debt

Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.

Amgen leads the 11 biotech ranked by total debt, at ZAR 940B, ahead of Gilead Sciences (ZAR 429.3B) and Biogen (ZAR 108.2B). Figures as of 18 Nov 2026, 14:31 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
11
First
AmgenZAR 940B
Median
ZAR 10.2B
Combined market value
ZAR 14.47T
Countries
5
Not ranked
13no total debt on file

Market values as of .

Largest biotech by total debt
#CompanyTotal debt ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AmgenAMGN · Health CareZAR 940BZAR 4.2TZAR 7,769.03 1.45% down 34% up United States
2Gilead SciencesGILD · Health CareZAR 429.3BZAR 3.58TZAR 2,889.09 1.43% down 33% up United States
3BiogenBIIB · Health CareZAR 108.2BZAR 628.5BZAR 4,251.96 1.51% down 49% up United States
4Halozyme TherapeuticsHALO · Health CareZAR 36.9BZAR 187.4BZAR 1,643.72 0.51% down 37% up United States
5QiagenQGEN · Health CareZAR 28.5BZAR 176.7BZAR 855.81 0.07% down 12% up Netherlands
6ModernaMRNA · Health CareZAR 10.2BZAR 1.43TZAR 3,528.78 0.88% down 755% up United States
7RepligenRGEN · Health CareZAR 9.3BZAR 183.8BZAR 2,874.80 2.97% up 5% up United States
8Bio-TechneTECH · Health CareZAR 3.4BZAR 196.7BZAR 1,251.83 0.12% up 26% up United States
9Adaptive BiotechnologiesADPT · Health CareZAR 2.3BZAR 79.5BZAR 491.13 0.14% up 88% up United States
10Scholar Rock HoldingSRRK · Health CareZAR 1.7BZAR 93BZAR 762.25 1.77% down 14% up United States
11CG OncologyCGON · Health CareZAR 51.6MZAR 123BZAR 1,377.15 1.34% up 85% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total debt is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Total debt is assembled from each company's debt lines and is the least complete of these figures: some companies tag part of their borrowings in ways it misses. Sums are converted from US dollars at today's exchange rate (1 USD = 17.2144 ZAR). 13 companies have no total debt on file and are not ranked here.

Questions and answers

Which biotech rank first by total debt?

Amgen (ZAR 940B), Gilead Sciences (ZAR 429.3B) and Biogen (ZAR 108.2B) are the top three of the 11 biotech ranked by total debt as of 18 Nov 2026, 14:31 UTC.

How many biotech are in this ranking?

11 are ranked by total debt. 13 more have no total debt on file and are left out rather than ranked at zero.

What are these biotech worth together?

The 11 biotech ranked by total debt have a combined market value of ZAR 14.47T as of 18 Nov 2026, 14:31 UTC.

What does ranking by total debt measure?

Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.

Cite this page

Funkfolio, “Largest biotech by total debt”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=total-debt

Underlying data: Yahoo Finance; SEC EDGAR.